AC Immune (ACIU) Enterprise Value (QoQ) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | AC Immune | 325.88 Mn | 211.53 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 15.67% |
| Sep 30, 2025 | 18.47% |
| Jun 30, 2025 | -2.69% |
| Mar 31, 2025 | -307.47% |
| Dec 31, 2024 | -1.28% |
| Sep 30, 2024 | 248.61% |
| Jun 30, 2024 | 158.66% |
| Mar 31, 2024 | 76.34% |
| Dec 31, 2023 | -92.62% |
| Sep 30, 2023 | -9.61% |
| Jun 30, 2023 | 28.73% |
| Mar 31, 2023 | 14.67% |
| Dec 31, 2022 | -90.52% |
| Sep 30, 2022 | 40.00% |
| Jun 30, 2022 | 40.86% |
| Mar 31, 2022 | 99.85% |
| Dec 31, 2021 | -386,602.54% |
| Sep 30, 2021 | -0.65% |
| Jun 30, 2021 | 100.05% |
| Mar 31, 2021 | -33,947.60% |
| Dec 31, 2020 | 3.57% |
| Sep 30, 2020 | -12.55% |
| Jun 30, 2020 | 32.27% |
| Mar 31, 2020 | -121.11% |
| Dec 31, 2019 | 16.04% |
| Sep 30, 2019 | 99.92% |
| Jun 30, 2019 | -118,584.60% |
| Mar 31, 2019 | 7.75% |
| Dec 31, 2017 | 20.30% |
| Sep 30, 2017 | -2.39% |
| Jun 30, 2017 | -12.33% |
| Mar 31, 2017 | 9.65% |
| Dec 31, 2016 | 2.44% |
| Sep 30, 2016 | 0.54% |